Cart
sales@molnova.com
ODM-207
CAS No. 1801503-93-4
ODM-207( BET-IN-4 | ODM-207 | ODM207 )
Catalog No. M26070 CAS No. 1801503-93-4
BET-IN-4 is a potent BRD4 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 86 | Get Quote |
|
| 5MG | 132 | Get Quote |
|
| 10MG | 215 | Get Quote |
|
| 25MG | 393 | Get Quote |
|
| 50MG | 565 | Get Quote |
|
| 100MG | 800 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameODM-207
-
NoteResearch use only, not for human use.
-
Brief DescriptionBET-IN-4 is a potent BRD4 inhibitor.
-
DescriptionBET-IN-4 is a potent BRD4 inhibitor.(In Vitro):BET-IN-4 inhibits BRD4 with an IC50?of ≤ 1 μM.
-
In VitroODM-207 (Compound 50) is a potent BET bromodomain protein (BRD4) inhibitor, with an IC50 of ≤ 1 μM.
-
In Vivo——
-
SynonymsBET-IN-4 | ODM-207 | ODM207
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1801503-93-4
-
Formula Weight375.428
-
Molecular FormulaC22H21N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (26.64 mM)
-
SMILESCOc1cc2n(Cc3ccccn3)c(=O)c(C)cc2cc1-c1c(C)noc1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kao-Lu Pan, et al. Identification of trans,trans-2,4-decadienal metabolites in mouse and human cells using liquid chromatography-mass spectrometry. Chem Res Toxicol. 2014 Oct 20;27(10):1707-19.
molnova catalog
related products
-
NEO2734
NEO2734 is an orally active and selective inhibitor of p300/CBP and BET bromodomain(IC50 of <30 nM for both p300/CBP and BET bromodomains).
-
ODM-207
BET-IN-4 is a potent BRD4 inhibitor.
-
J147
J-147 is a broad spectrum neuroprotective phenyl hydrazide compound(EC50=60-115 nM) with significant neurotrophic properties related to the induction of brain-derived neurotrophic factor (BDNF).
